Enzymatica AB engages in the research, development, and sale of medical technology products. It offers medical devices in upper respiratory infections and oral health. The company was founded by Ulf Blom, Jorgen Rexo, Ake Larsson, and Staffan Bergqvist in 2007 and is headquartered in Lund, Sweden.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company